A model-based analysis: What potential could there be for a S. aureus vaccine in a hospital setting on top of other preventative measures?

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Hogea, Cosmina ^a   Van Effelterre, Thierry ^b   Cassidy, Adrian ^b  

^a GLAXOSMITHKLINE   (United States)

^b GSK   (Belgium)

Author keywords

Hospital infection; Infection reduction; Mathematical modelling; MRSA; Preventative measures; Vaccination

Indexed keywords

STAPHYLOCOCCUS VACCINE;

ACTIVE IMMUNIZATION; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; DRUG EFFICACY; HOSPITAL ADMISSION; HOSPITAL HYGIENE; INFECTION PREVENTION; MATHEMATICAL ANALYSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PREVENTIVE MEDICINE; FEMALE; HOSPITAL; HUMAN; IMMUNOLOGY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PATHOGENICITY; PUBLIC HEALTH; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; THEORETICAL MODEL; VACCINATION;

FEMALE; HOSPITALS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MODELS, THEORETICAL; PUBLIC HEALTH; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS; VACCINATION;

EID: 84902085783     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-291     Document Type: Article

References (45)

1. Mostofsky E, Lipsitch M, Regev-Yochay G. Is methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S. aureus?. J Antimicrob Chemother 2011, 66:2199-2214. 10.1093/jac/dkr278, 3172038, 21737459.
2. Lee AS, Huttner B, Harbarth S. Control of methicillin-resistant Staphylococcus aureus. Infect Dis Clin North AM 2011, 25:155-179. 10.1016/j.idc.2010.11.002, 21315999.
3. Barrett FF, McGehee RF, Finland M. Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. N Engl J Med 1968, 279:441-448. 10.1056/NEJM196808292790901, 4232865.
4. Carleton HA, Diep BA, Charlebois ED, Sensabaugh GF, Perdreau-Remington F. Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA. J Infect Dis 2004, 190:1730-1738. 10.1086/425019, 15499526.
5. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como Sabetti K, Jernigan JA, Harriman K, Harrison LH, Lynfield R, Farley MM, . Active Bacterial Core Surveillance Program of the Emerging Infections Program Network Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005, 352:1436-1444. 10.1056/NEJMoa043252, 15814879, Active Bacterial Core Surveillance Program of the Emerging Infections Program Network.
6. Mera RM, Suaya JA, Amrine-Madsen H, Hogea CS, Miller LA, Lu EP, Sahm DF, O'Hara P, Acosta CJ. Increasing role of Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus infections in the United States: a 10-year trend of replacement and expansion. Microb Drug Resist 2011, 17:321-328. 10.1089/mdr.2010.0193, 21417776.
7. European Centre for Disease Prevention and Control Surveillance of healthcare-associated infections in Europe 2012, Stockholm: ECDC, European Centre for Disease Prevention and Control.
8. Pearson A, Chronias A, Murray M. Voluntary and mandatory surveillance for methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) bacteraemia in England. J Antimicrob Chemother 2009, 64(Suppl. 1):i11-i17.
9. US Department of Health and Human Services National Action Plan to Prevent Health Care-Associated Infections: Road Map to Elimination. 2014, [http://www.health.gov/hai/prevent_hai.asp], US Department of Health and Human Services.
10. Chaberny IF, Schwab F, Ziesing S, Suerbaum S, Gastmeier P. Impact of routine surgical ward and intensive care unit admission surveillance cultures on hospital-wide nosocomial methicillin-resistant Staphylococcus aureus infections in a university hospital: an interrupted time-series analysis. J Antimicrob Chemother 2008, 62:1422-1429. 10.1093/jac/dkn373, 18765411.
11. Harbarth S, Fankhauser C, Schrenzel J, Christenson J, Gervaz P, Bandiera-Clerc C, Renzi G, Vernaz N, Sax H, Pittet D. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008, 299:1149-1157. 10.1001/jama.299.10.1149, 18334690.
12. Huang SS, Yokoe DS, Hinrichsen VL, Spurchise LS, Datta R, Miroshnik I, Platt R. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2006, 43:971-978. 10.1086/507636, 16983607.
13. Ridenour G, Lampen R, Federspiel J, Kritchevsky S, Wong E, Climo M. Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients. Infect Control Hosp Epidemiol 2007, 28:1155-1161. 10.1086/520102, 17828692.
14. Robicsek A, Beaumont JL, Paule SM, Hacek DM, Thomson RB, Kaul KL, King P, Peterson LR. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 2008, 148:409-418. 10.7326/0003-4819-148-6-200803180-00003, 18347349.
15. Walsh EE, Greene L, Kirshner R. Sustained reduction in methicillin-resistant Staphylococcus aureus wound infections after cardiothoracic surgery. Arch Intern Med 2011, 171:68-73.
16. Huskins WC, Huckabee CM, O'Grady NP, Murray P, Kopetskie H, Zimmer L, Walker ME, Sinkowitz-Cochran RL, Jernigan JA, Samore M, Wallace D, Goldmann DA, . STAR*ICU Trial Investigators Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med 2011, 364:1407-1418. 10.1056/NEJMoa1000373, 3410743, 21488763, STAR*ICU Trial Investigators.
17. Chen YC, Sheng WH, Wang JT, Chang SC, Lin HC, Tien KL, Hsu LY, Tsai KS. Effectiveness and limitations of hand hygiene promotion on decreasing healthcare-associated infections. PLoS One 2011, 6:e27163. 10.1371/journal.pone.0027163, 3217962, 22110610.
18. Jain R, Kralovic SM, Evans ME, Ambrose M, Simbartl LA, Obrosky DS, Render ML, Freyberg RW, Jernigan JA, Muder RR, Miller LJ, Roselle GA. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med 2011, 364:1419-1430. 10.1056/NEJMoa1007474, 21488764.
19. Proctor RA. Challenges for a universal Staphylococcus aureus vaccine. Clin Infect Dis 2012, 54:1179-1186. 10.1093/cid/cis033, 22354924.
20. Guggenbichler JP, Assadian O, Boeswald M, Kramer A. Incidence and clinical implication of nosocomial infections associated with implantable biomaterials - catheters, ventilator-associated pneumonia, urinary tract infections. GMS Krankenhhyg Interdiszip 2011, 6:18.
21. VacZine Analytics New vaccines for Staphylococcus aureus: risk-based or population-based approach?. 2008, [http://www.vaczine-analytics.com/ER_April_20080412.pdf], VacZine Analytics.
22. Steenhuysen J. Pfizer takes its shot at a vaccine for evasive superbug 2013, [http://www.reuters.com/article/2013/05/23/pfizer-vaccine-idUSL2N0DK0TY20130523].
23. D'Agata EM, Webb GF, Horn MA, Moellering RC, Ruan S. Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals. Clin Infect Dis 2009, 48:274-284. 10.1086/595844, 2666259, 19137654.
24. Webb GF, Horn MA, D'Agata EM, Moellering RC, Ruan S. Competition of hospital-acquired and community-acquired methicillin-resistant Staphylococcus aureus strains in hospitals. J Biol Dyn 2010, 4:115-129. 10.1080/17513750903026411, 2706519, 19587839.
25. Klein EY, Sun L, Smith DL, Laxminarayan R. The Changing Epidemiology of Methicillin-Resistant Staphylococcus aureus in the United States: A National Observational Study. Am J Epidemiol 2013, 177:666-674. 10.1093/aje/kws273, 23449778.
26. Adegbola RA, Secka O, Lahai G, Lloyd-Evans N, Njie A, Usen S, Oluwalana C, Obaro S, Weber M, Corrah T, Mulholland K, McAdam K, Greenwood B, Milligan PJ. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet 2005, 366:144-150. 10.1016/S0140-6736(05)66788-8, 16005337.
27. Hammitt LL, Bruden DL, Butler JC, Baggett HC, Hurlburt DA, Reasonover A, Hennessy TW. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease. J Infect Dis 2006, 193:1487-1494. 10.1086/503805, 16652275.
28. Maiden MC, Ibarz-Pavón AB, Urwin R, Gray SJ, Andrews NJ, Clarke SC, Walker AM, Evans MR, Kroll JS, Neal KR, Ala'aldeen DA, Crook DW, Cann K, Harrison S, Cunningham R, Baxter D, Kaczmarski E, Maclennan J, Cameron JC, Stuart JM. Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J Infect Dis 2008, 197:737-743. 10.1086/527401, 18271745.
29. Trotter CL, McVernon J, Ramsay ME, Whitney CG, Mulholland EK, Goldblatt D, Hombach J, Kieny MP, . SAGE subgroup Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae. Vaccine 2008, 26:4434-4445. 10.1016/j.vaccine.2008.05.073, 18617296, SAGE subgroup.
30. Van Effelterre T, Moore MR, Fierens F, Whitney CG, White L, Pelton SI, Hausdorff WP. A dynamic model of pneumococcal infection in the United States: Implications for prevention through vaccination. Vaccine 2010, 28:3650-3660. 10.1016/j.vaccine.2010.03.030, 20359560.
31. Brauer F, Driessche P, Wu J. Mathematical Epidemiology (Lecture Notes in Mathematics/Mathematical Biosciences Subseries) 2008, Heidelberg: Springer-Verlag.
32. Boyce JM, Pittet D, . Healthcare Infection Control Practices Advisory Committee; HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force Guideline for Hand Hygiene in Health-Care Settings: Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR Recomm Rep 2002, 51:1-45. No. RR-16, Healthcare Infection Control Practices Advisory Committee; HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force.
33. Pittet D, Hugonnet S, Harbarth S, Mourouga P, Sauvan V, Touveneau S, Perneger TV. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infect Control Programme Lancet 2000, 356:1307-1312.
34. Inside Duke Medicine Hand hygiene compliance improves with monitoring program. 2010, [http://insidedukemedicine.org/news/hand-hygiene-compliance-improves-with-monitoring-program/], Inside Duke Medicine.
35. Gould DJ, Moralejo D, Drey N, Chudleigh JH. Interventions to improve hand hygiene compliance in patient care. Cochrane Database 2010, 9:CD005186.
36. Shinefield H, Black S, Fattom A, Horwith G, Rasgon S, Ordonez J, Yeoh H, Law D, Robbins JB, Schneerson R, Muenz L, Fuller S, Johnson J, Fireman B, Alcorn H, Naso R. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med 2002, 346:491-496. 10.1056/NEJMoa011297, 11844850.
37. Kourbatova EV, Halvosa JS, King MD, Ray SM, White N, Blumberg HM. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections. Am J Infect Control 2005, 33:385-391. 10.1016/j.ajic.2005.06.006, 16153484.
38. Paez A, Skiest D. Methicillin-resistant Staphylococcus aureus: from the hospital to the community. Curr Infect Dis Rep 2008, 10:14-21. 10.1007/s11908-008-0005-z, 18377810.
39. Seybold U, Kourbatova EV, Johnson JG, Halvosa SJ, Wang YF, King MD, Ray SM, Blumberg HM. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006, 42:647-656. 10.1086/499815, 16447110.
40. Huang SS, Hinrichsen VL, Datta R, Spurchise L, Miroshnik I, Nelson K, Platt R. Methicillin-resistant Staphylococcus aureus infection and hospitalization in high-risk patients in the year following detection. PLoS One 2011, 6:e24340. 10.1371/journal.pone.0024340, 3174953, 21949707.
41. National Center for Health Statistics United States, 2012: With Special Feature on Emergency Care 2013, Hyattsville, MD, USA, National Center for Health Statistics.
42. Ingraham AM, Cohen ME, Raval MV, Ko CY, Nathens AB. Comparison of hospital performance in emergency versus elective general surgery operations at 198 hospitals. J Am Coll Surg 2011, 212:20-28. 10.1016/j.jamcollsurg.2010.09.026, 21184955.
43. US News Health Hospitals Hospital for Special Surgeryin New York, NY: stats and services 2013, [http://health.usnews.com/best-hospitals/area/ny/hospital-for-special-surgery-6212900/details], US News Health Hospitals.
44. Joice R, Lipsitch M. Targeting Imperfect Vaccines against Drug-Resistance Determinants: A Strategy for Countering the Rise of Drug Resistance. PLoS One 2013, 8:e68940. 10.1371/journal.pone.0068940, 3723804, 23935910.
45. Zorman JK, Esser M, Raedler M, Kreiswirth BN, Ala'aldeen DA, Kartsonis N, Smugar SS, Anderson AS, McNeely T, Arduino JM. Naturally occurring IgG antibody levels to the Staphylococcus aureus protein IsdB in humans. Hum Vaccin Immunother 2013, 9:1857-1864.